Bjorklund Hakan 4
4 · Organogenesis Holdings Inc. · Filed Dec 12, 2018
Insider Transaction Report
Form 4
Bjorklund Hakan
Director
Transactions
- Disposition to Issuer
Class B Ordinary Shares
2018-12-10−243,896→ 69,571 total→ Class A Ordinary Shares (243,896 underlying)
Footnotes (2)
- [F1]Pursuant to the Amended and Restated Memorandum and Articles of Association (the "Articles") of Avista Healthcare Public Acquisition Corp. (the "Issuer"), the Class B ordinary shares, par value $0.0001 per share (the "Class B Shares") will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the Issuer at the time of the Issuer's Business Combination, as defined in the Articles, on a one-for-one basis, subject to adjustment, and have no expiration date.
- [F2]243,896 Class B ordinary shares were forfeited to the Issuer for no consideration prior to the closing of the Business Combination.